Works by Gao, Guanghui

Results: 65
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Integrated wafer-scale ultra-flat graphene by gradient surface energy modulation.

    Published in:
    Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-33135-w
    By:
    • Gao, Xin;
    • Zheng, Liming;
    • Luo, Fang;
    • Qian, Jun;
    • Wang, Jingyue;
    • Yan, Mingzhi;
    • Wang, Wendong;
    • Wu, Qinci;
    • Tang, Junchuan;
    • Cao, Yisen;
    • Tan, Congwei;
    • Tang, Jilin;
    • Zhu, Mengjian;
    • Wang, Yani;
    • Li, Yanglizhi;
    • Sun, Luzhao;
    • Gao, Guanghui;
    • Yin, Jianbo;
    • Lin, Li;
    • Liu, Zhongfan
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33

    EGFR‐TKIs plus local therapy demonstrated survival benefit than EGFR‐TKIs alone in EGFR‐mutant NSCLC patients with oligometastatic or oligoprogressive liver metastases.

    Published in:
    International Journal of Cancer, 2019, v. 144, n. 10, p. 2605, doi. 10.1002/ijc.31962
    By:
    • Jiang, Tao;
    • Chu, Qian;
    • Wang, Huijuan;
    • Zhou, Fei;
    • Gao, Guanghui;
    • Chen, Xiaoxia;
    • Li, Xuefei;
    • Zhao, Chao;
    • Xu, Qinghua;
    • Li, Wei;
    • Wu, Fengying;
    • Xiong, Anwen;
    • Zhao, Jing;
    • Xu, Yaping;
    • Su, Chunxia;
    • Ren, Shengxiang;
    • Zhou, Caicun;
    • Hirsch, Fred R.
    Publication type:
    Article
    34
    35
    36
    37

    Larger tumors are associated with inferior progression‐free survival of first‐line EGFR‐tyrosine kinase inhibitors and a lower abundance of EGFR mutation in patients with advanced non‐small cell lung cancer.

    Published in:
    Thoracic Cancer, 2019, v. 10, n. 4, p. 686, doi. 10.1111/1759-7714.12986
    By:
    • Pan, Yingying;
    • Gao, Guanghui;
    • Chen, Xiaoxia;
    • Tian, Qinrui;
    • Wu, Fengying;
    • Liu, Qian;
    • Wang, Yan;
    • Jiang, Tao;
    • Liu, Yiwei;
    • Li, Xuefei;
    • Yang, Shuo;
    • Xu, Chuan;
    • Su, Chunxia;
    • Zhou, Fei;
    • Ren, Shengxiang;
    • Zhou, Caicun
    Publication type:
    Article
    38
    39
    40
    41
    42

    Toripalimab plus chemotherapy as second-line treatment in previously EGFR-TKI treated patients with EGFR-mutant-advanced NSCLC: a multicenter phase-II trial.

    Published in:
    Signal Transduction & Targeted Therapy, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41392-021-00751-9
    By:
    • Jiang, Tao;
    • Wang, Pingyang;
    • Zhang, Jie;
    • Zhao, Yanqiu;
    • Zhou, Jianying;
    • Fan, Yun;
    • Shu, Yongqian;
    • Liu, Xiaoqing;
    • Zhang, Helong;
    • He, Jianxing;
    • Gao, Guanghui;
    • Mu, Xiaoqian;
    • Bao, Zhang;
    • Xu, Yanjun;
    • Guo, Renhua;
    • Wang, Hong;
    • Deng, Lin;
    • Ma, Ningqiang;
    • Zhang, Yalei;
    • Feng, Hui
    Publication type:
    Article
    43

    Toripalimab plus chemotherapy as second-line treatment in previously EGFR-TKI treated patients with EGFR-mutant-advanced NSCLC: a multicenter phase-II trial.

    Published in:
    Signal Transduction & Targeted Therapy, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41392-021-00751-9
    By:
    • Jiang, Tao;
    • Wang, Pingyang;
    • Zhang, Jie;
    • Zhao, Yanqiu;
    • Zhou, Jianying;
    • Fan, Yun;
    • Shu, Yongqian;
    • Liu, Xiaoqing;
    • Zhang, Helong;
    • He, Jianxing;
    • Gao, Guanghui;
    • Mu, Xiaoqian;
    • Bao, Zhang;
    • Xu, Yanjun;
    • Guo, Renhua;
    • Wang, Hong;
    • Deng, Lin;
    • Ma, Ningqiang;
    • Zhang, Yalei;
    • Feng, Hui
    Publication type:
    Article
    44

    Toripalimab plus chemotherapy as second-line treatment in previously EGFR-TKI treated patients with EGFR-mutant-advanced NSCLC: a multicenter phase-II trial.

    Published in:
    Signal Transduction & Targeted Therapy, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41392-021-00751-9
    By:
    • Jiang, Tao;
    • Wang, Pingyang;
    • Zhang, Jie;
    • Zhao, Yanqiu;
    • Zhou, Jianying;
    • Fan, Yun;
    • Shu, Yongqian;
    • Liu, Xiaoqing;
    • Zhang, Helong;
    • He, Jianxing;
    • Gao, Guanghui;
    • Mu, Xiaoqian;
    • Bao, Zhang;
    • Xu, Yanjun;
    • Guo, Renhua;
    • Wang, Hong;
    • Deng, Lin;
    • Ma, Ningqiang;
    • Zhang, Yalei;
    • Feng, Hui
    Publication type:
    Article
    45
    46
    47
    48
    49
    50